Description
BPC-157 supplied as a research reagent for in-vitro laboratory use. Every lot is assayed by reverse-phase HPLC to ≥98% purity, with identity confirmed by mass spectrometry and residual water content checked by Karl Fischer titration. Purity is verified across multiple independent laboratories, and material is sourced across multiple manufacturers so the highest-purity batch can be selected for release.
Specification
- CAS number: 137525-51-0
- Physical form: Lyophilised powder
- Purity: ≥98% by RP-HPLC
- Storage: 2°C – 8°C, protect from light
Research findings
- Studied in preclinical models of tendon, ligament and muscle injury, where accelerated healing has been reported [2]
- Investigated for effects on gastrointestinal mucosal integrity, including in models of induced ulceration [3]
- Laboratory testing has examined its interaction with the nitric oxide system, with reported involvement of eNOS-derived signalling [1]
- Reported in preclinical work to influence the formation of new blood vessels and collateral pathways at injury sites [3]
- Examined for effects on growth-factor receptor expression in tendon-derived cells [2]
Regulatory status
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for in-vitro laboratory research by qualified professionals. Not a medicine, supplement, cosmetic or food. Must not be administered to humans or animals.
Vial and carton labels show 99% purity — the specification we aim for on every batch. Our guaranteed minimum is ≥98% by RP-HPLC, and the measured result for each batch appears on its certificate of analysis.
Reviews
There are no reviews yet.